A theme barely three years old, so the book literature is almost nonexistent. The serious analysis is in sell-side research, Novo Nordisk and Eli Lilly disclosures, and the New England Journal trial papers; the books below are context rather than investment cases.
Background on how the obesity market got as large as it is.
Recommended by: Vinod Khosla
The brain's appetite circuits, why people overeat and why diets fail.
The GLP-1 drugs: their benefits, their risks and their effects on society.